CAS 1232861-58-3

Gemilukast

CAS : 1232861-58-3

Gemilukast

Degré de pureté : ≥98%

Masse moléculaire : 601.68g/mol

Ref: 54-BUP11484

Gemilukast

CAS : 1232861-58-3

Gemilukast is a leukotriene receptor antagonist that inhibits the action of leukotrienes and has been shown to be effective in treating chronic cough. It also has anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis. Gemilukast is used in the treatment of age-related macular degeneration (AMD) and respiratory diseases, including chronic obstructive pulmonary disease (COPD). The drug is administered orally and is well tolerated by patients. Gemilukast's effects are related to its ability to inhibit compounds involved in inflammation, such as neurokinin-1, which causes bronchoconstriction and airway narrowing.

Formule : C₃₆H₃₇F₂NO₅

Degré de pureté : Min. 95%

Masse moléculaire : 601.7 g/mol

Ref: 3D-HZB86158

Gemilukast

CAS : 1232861-58-3

Gemilukast (ONO-6950) is a cysteinyl leukotriene 1 and 2 receptor inhibitor that inhibits bronchoconstriction and is used in the treatment of asthma.

Formule : C₃₆H₃₇F₂NO₅

Degré de pureté : 98.27% - 99.5%

Couleur et forme : Solid

Masse moléculaire : 601.68

Ref: TM-T11388